Learn more

WISTA LAB LTD

Overview
  • Total Patents
    320
  • GoodIP Patent Rank
    12,810
  • Filing trend
    ⇩ 83.0%
About

WISTA LAB LTD has a total of 320 patent applications. It decreased the IP activity by 83.0%. Its first patent ever was published in 1996. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are LIGAND PHARMACEUTICALS INCORPORATED, TEVA PHARMACEUTICAL INDUSTRIES LTD and Grünenthal GmbH .

Patent filings per year

Chart showing WISTA LAB LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wischik Claude Michel 178
#2 Storey John Mervyn David 162
#3 Harrington Charles Robert 116
#4 Sinclair James Peter 107
#5 Horsley David 96
#6 Marshall Colin 92
#7 Rickard Janet Elizabeth 89
#8 Baddeley Thomas Craven 53
#9 Clunas Scott 47
#10 Wischik Damon Jude 37

Latest patents

Publication Filing date Title
GB202016955D0 Therapeutic treatments
GB202016957D0 Beneficial treatment
GB202010679D0 Methods of providing modulators of Tau aggregation
GB202010620D0 System
GB202010652D0 Anti-tau antibodies
GB202006659D0 Therapeutic treatments
AU2019308873A1 Optimised dosage of diaminophenothiazines in populations
GB201909506D0 Synaptopathies
GB201909454D0 Enhancers
GB201909458D0 Optimised dosage of diaminophenothiazines in populations
GB201909493D0 Therapeutic interactions
GB201812193D0 Optimised dosage of diaminophenothiazines in populations
US2020016165A1 Administration and dosage of diaminophenothiazines
GB201710382D0 Administration and dosage of Diaminophenothiazines
GB201621817D0 Methods of chemical synthesis
GB201614834D0 Treatment of dementia
GB201612863D0 Administration and dosage of diaminophenothiazines
AU2016202982A1 Crystalline methylthionium chloride (methylene blue) hydrates
GB201512678D0 Methods of chemical synthesis
AU2014280990A1 3,6-disubstituted xanthylium salts as medicaments